Total planned funding: $277,726,449
Allocations
Countries/Regions
Eswatini | $277,726,449 |
Organizational Types
Private Contractor | $82,354,294 |
University | $52,549,839 |
NGO | $48,699,759 |
Own Agency | $34,237,933 |
Unknown | $31,885,031 |
Multi-lateral Agency | $9,554,780 |
FBO | $8,611,975 |
Host Country Government Agency | $8,395,539 |
Other USG Agency | $1,410,468 |
Implementing Agency | $26,831 |
Program Areas
Care | $91,204,228 |
Treatment | $72,675,051 |
Prevention | $45,930,170 |
Governance and Systems | $26,929,979 |
Testing | $23,120,938 |
Management and Operations | $17,866,083 |
Budget Codes
HTXS: Treatment: Adult Treatment | $51,799,538 |
HBHC: Care: Adult Care and Support | $41,699,123 |
HKID: Care: Orphans and Vulnerable Children | $28,747,686 |
HVCT: Testing: HIV Testing and Counseling | $23,120,938 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,622,142 |
HVMS: Management and Operations | $17,866,083 |
HTXD: Treatment: ARV Drugs | $16,066,298 |
HVOP: Sexual Prevention: Other Sexual Prevention | $14,852,384 |
HVTB: Care: TB/HIV | $12,920,197 |
OHSS: Health Systems Strengthening | $12,570,870 |
HVSI: Strategic Information | $10,201,896 |
PDCS: Care: Pediatric Care and Support | $7,837,222 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,412,446 |
PDTX: Treatment: Pediatric Treatment | $4,809,215 |
HLAB: Laboratory Infrastructure | $4,157,213 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,131,227 |
HMBL: Biomedical Prevention: Blood Safety | $911,971 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$44,226,997
Countries/Regions
Pact, Inc.:
$30,079,701
Countries/Regions
Not Available:
$27,486,045
Countries/Regions
USG Aggregated Agencies:
$21,027,181
Countries/Regions